C.R. Bard Settles Vaginal Mesh Lawsuits for $200M

C.R. Bard settles vaginal mesh lawsuits for $200M. This agreement comes after five years of expensive legal battles. Over 3,000 women claiming that implantation of Bard’s bladder or vaginal sling caused them injuries filed the suits being settled. The products are commonly used in surgeries treating stress urinary incontinence or pelvic organ prolapse. This isn’t

Lovaza May Cause Subdural Hematoma

Lovaza, a popular prescription Omega-3 fish oil, may cause subdural hematoma. Omega-3s, essential for human health, may also contribute to increased risk of bleeding. As many who suffer from chronic subdural hematoma are elderly and, therefore, more likely to need Lovaza, this risk increases. To date, GSK’s warning does not include subdural hematoma.

Psych Ward Escapee Dies in Traffic, Court Rules Medical Malpractice

Psych ward escapee dies in traffic, court rules medical malpractice. After Ashley Lawson, patient as Shands Vista psychiatric hospital, stole an employee’s badge and keys, she escaped and fled onto Interstate 75 where she was killed when a truck hit her. Her estate sued the hospital for negligence, but the 1st District Court of Appeal ruled that it properly sounded in medical malpractice. This resulted in the case being dismissed as the estate didn’t meet the notice provisions for a medmal case. However, it was dismissed without prejudice, meaning the estate can try again.

Valeant Strikes Collaboration Deal with AstraZeneca over Experimental Psoriasis Drug

The terms of the agreement include Valeant paying AstraZeneca $100 million up front, adding another $170 million depending on pre-launch benchmarks, as well as up to $175 million depending upon sales benchmarks. After the product’s launch, the two companies will share profits. Valeant will handle the regulatory submission processes and the associated costs. In return, Valeant will retain the commercialization rights to brodalumab in all markets except in Japan and some Asian countries, where Amgen, the originator of the drug, had made a pre-existing agreement with Japanese biotech firm Kyowa Hakko Kirin.

Baby Born with One Kidney Due to Zofran Use

Another Zofran lawsuit has been filed against GlaxoSmithKline alleging that the drug causes birth defects. G.K., a male child, was born without one kidney. He is also missing the connective tissues that would make a kidney transplant possible. Other birth defects include a deferens that is not fully functional, a defect that may limit G.K.’s sexual function as an adult and make it impossible for him to father a child.

Miracle Recalls Tainted Weight Loss Pill and Male Enhancer

The One Minute Miracle, Inc. recalls two of its products, Miracle Diet 30 and Miracle Rock 48, supplements for weight loss and male enhancement respectively. The recall comes after finding that the products may be tainted with a banned laxative and an analogue to Viagra. Using the products may put consumers in danger. The company urges all consumers to stop using the products immediately. The One Minute Miracle, Inc. is also recalling many of its other products, such as Miracle Cougar Gum, due to safety concerns.

Marcy Borders, 9/11 ‘Dust Lady,’ Dies of Cancer at 42

Borders’s death is a stark reminder that many of those who endured the 9/11 tragedy are suffering from long-term health problems. Borders was asked if she thought that the debris from the terror attack, which contained glass and other carcinogenic dust, among other dangerous particles led to her cancer. She responded, “I’m saying to myself, ‘Did this thing ignite cancer cells in me?’ I definitely believe it because I haven’t had any illnesses. I don’t have high blood pressure, high cholesterol, diabetes.”

Judge Dismisses Part of Plavix Multidistrict False Claims Lawsuit

Judge Freda Wolfson of the U.S. District of New Jersey has granted some relief for drugmakers Bristol-Myers Squibb and Sanofi-Aventis in a complicated multidistrict whistleblower lawsuit against the two companies over marketing claims involving the blood-thinning medication Plavix. Wolfson granted motions to dismiss several claims made by former Sanofi sales representative Elisa Dickson, alleging that

FTC Urges FDA to Re-evaluate Homeopathic Product Regulation

The $3 billion industry has increasingly drawn the attention of both regulators. Among the questions the FDA brought up in the request for comment involve consumer and health provider attitudes towards homeopathic products, requests for data sources regarding the safety of the products, and what kind of measures could be implemented to improve the clarity of the CPG’s standard, among others.